A report published in JAMA Oncology suggested that pediatric patients with cancer may not be more vulnerable than other children to infection or morbidity resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
“Together, our results do not support the conjecture that children are a reservoir of unrecognized SARS-CoV-2 infection,” the authors wrote.
Starting in mid-March 2020, researchers in the Memorial Sloan Kettering Cancer Center (MSK) Kids pediatric program instituted a screening and testing plan to mitigate risks associated with the coronavirus disease 2019 (COVID-19).
On submission for outpatient or inpatient care, patients were screened for the presence of symptoms of COVID-19 or exposure to contacts with known SARS-CoV-2 infection. Additionally, testing for SARS-CoV-2 was instituted using a RT-PCR assay for 3 cohorts of individuals, including…